ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients
Barnabas Gellen(Centre Hospitalier Universitaire Henri-Mondor), Samy Hadjadj(Université de Poitiers), M. Fraty(Centre Hospitalier Universitaire de Poitiers), Grégory Ducrocq, Stéphanie Ragot(Université de Tours), Éric Thorin(Montreal Heart Institute), Vincent Rigalleau(Université de Bordeaux), Elise Gand(Université de Poitiers), P. Llaty(Université de Poitiers), Ronan Roussel(Lyon 1 Université), David Montaigne(Centre Hospitalier Universitaire de Lille), Jean‐Michel Halimi(Centre Hospitalier Universitaire de Tours), Philippe Zaoui(Centre Hospitalier Universitaire de Grenoble), P. Sosner(Inserm), Nathalie Thorin‐Trescases(Montreal Heart Institute), Stéphanie Laugier(Université de Poitiers), Pierre‐Jean Saulnier(Inserm)
Cited by 36
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Association of Cardiometabolic Multimorbidity With Mortality
|JAMA|2015|1.2k
PPAR control of metabolism and cardiovascular functions
|Nature Reviews Cardiology|2021|901
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302